Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 7 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

4Total
Not Applicable (4)

Trial Status

Not Yet Recruiting4
Recruiting3

Clinical Trials (7)

Showing 7 of 7 trials
NCT07402057Not ApplicableRecruitingPrimary

Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations

NCT07440433Not ApplicableNot Yet Recruiting

Home-Based Physiotherapy in Oncology

NCT07387770Not ApplicableNot Yet RecruitingPrimary

Muscle Deterioration in Hospitalized Cancer Patient

NCT07384013Not ApplicableRecruitingPrimary

Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs

NCT07206927Not Yet RecruitingPrimary

Analysis of the Determinants of the Participation of Patients and Health Professionals of the University Hospital Center of Martinique in Clinical Research Protocols in Medical Oncology (StudyOrec)

NCT07175350RecruitingPrimary

Financial Toxicity (FT) for Radiotherapy (RT) Patients in Italy: a yAIRO (Associazione Italiana Radioterapia e Ocologia Clinica) Multicenter Study

NCT06626932Not Yet RecruitingPrimary

Implications of Biological and Procedural Factors of 18-f FDG Uptake by Normal Organs and Neoplastic Lesions

Showing all 7 trials

Research Network

Activity Timeline